GLYBURIDE
- Product NDC
- 62135-583
- 11-digit product format
- 621350583
- Labeler code
- 62135
- Product ID
- 62135-583_458a6ce1-673d-85c7-e063-6294a90a3577
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GLYBURIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA090937
- Marketing category
- ANDA
- Marketing start
- 2010-10-05
- Substance
- GLYBURIDE
- Active strength
- 1.25 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GLYBURIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLYBURIDE | 1.25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SX6K58TVWC |
| Rxcui | 197737, 310534, 310537 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-583-30 | GLYBURIDE | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-583 | GLYBURIDE TABLET [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20241030_7e661288-2d24-4403-86a1-754afa1d04ff.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-583-30 | 62135058330 | 30 TABLET in 1 BOTTLE (62135-583-30) | 30 tablet | 2023-05-09 | No | No | Current |